Q&A: How IQVIA Keeps Pharmacists Engaged with US Prescription Drug Use
Drug Topics
JULY 14, 2025
Often those very high-end medicines are for very few people.
Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers
Pharmacy Times
JULY 16, 2025
The findings of the DeLLphi-304 study demonstrated improved OS of tarlatamab compared with single-agent chemotherapy (median OS [mOS], 13.6 The updated definition for HRMM is increasingly important as there is an increased focus on how to improve outcomes for patients with HRMM, functional HRMM, and true extramedullary disease.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharmacist’s Role Expands in the Era of Cannabis Rescheduling
Drug Topics
AUGUST 12, 2025
If the DEA approves this move, medical marijuana will join other medications containing the synthetic psychoactive compound THC, which are dronabinol (Marinol [Schedule III] and Syndros [Schedule II]) and nabilone (Cesamet [Schedule II]). Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. 2021;81(13):1513-1557.
Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC
Pharmacy Times
JUNE 9, 2025
SHOW MORE Nivolumab (Opdivo) and chemotherapy demonstrated an overall survival benefit at 5 years, affirming its role as a standard of care option. 1,2 Nivolumab and chemotherapy is a standard of care option for resectable non-small cell lung cancer.
New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma
Pharmacy Times
JUNE 27, 2025
Because of its aggressive nature, MCL is typically treated with combination chemotherapy at diagnosis. For this application, the FDA collaborated with the Australian Therapeutic Goods Administration, Health Canada, and Switzerland’s Swissmedic.
Zongertinib Approved by FDA for Patients With Nonsquamous NSCLC With HER2 TKD Mutations
Pharmacy Times
AUGUST 8, 2025
2 In patients who had received prior platinum-based chemotherapy but had not been treated with a HER2-targeted TKI or antibody-drug conjugate (ADC; n = 71), the ORR was approximately 75% (95% CI, 63–83), with 58% of patients achieving a DOR of at least 6 months.
Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment
Pharmacy Times
JUNE 9, 2025
Related Videos Related Content Advertisement June 9th 2025 Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2. N Engl J Med. 2019;380:2020-2030. Subscribe Now!
Pharmacies Need Strategies to Improve Health Care Access
Pharmacy Times
JUNE 18, 2025
Martino, PharmD, BCOP, APh Kaitlyn Wells, PharmD Sam Martinez, PharmD, BCOP, BCPS Craig A. Martino, PharmD, BCOP, APh Kaitlyn Wells, PharmD Sam Martinez, PharmD, BCOP, BCPS Craig A.
Evaluation of a Pharmacy-Delivered Oncofertility Intervention
Pharmacy Times
JUNE 11, 2025
Approximately 40% to 80% of patients with cancer who are assigned female at birth face possible infertility as a result of their cancer treatments, such as chemotherapy, radiation, and surgery. An additional 15% to 30% of cancer survivors who are assigned male at birth also face infertility as a result of chemotherapy.
How to help patients avoid food poisoning
The Checkup by Singlecare
AUGUST 7, 2025
coli, associated with undercooked beef and contaminated produce Listeria, which can grow even in refrigeration, and affects high-risk individuals Seasonal activities compound the problem. Common summer foodborne pathogens include: Salmonella, linked to undercooked poultry and eggs Campylobacter, often found in undercooked chicken E.
The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications
Pharmacy Times
JUNE 17, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Immunotherapy Takes the Lead in Advanced Cutaneous Malignancies
Pharmacy Times
JUNE 20, 2025
Blood cancer patients are usually at higher risk due to prior chemotherapy, and maybe we don’t need the same kind of prophylactic medications for solid tumor patients. I think we’re getting to the point now where hematology and oncology both need services that can manage these types of side effects. The infection risks are a little different.
Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement
Pharmacy Times
JUNE 23, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape
Pharmacy Times
JUNE 12, 2025
Clinical Applications and Economic Impacts Biologics have significantly impacted cancer therapies by targeting cancer cells more specifically and reducing adverse events compared with traditional chemotherapy, Darkow noted.
How AI Brings Pharmacogenetics to the Frontline of Precision Medicine
Pharmacy Times
JULY 22, 2025
A man aged 55 years with metastatic colorectal cancer was initiated on a standard fluoropyrimidine-based chemotherapy regimen. Within a week, he developed severe neutropenia, gastrointestinal shutdown, and septic complications requiring admission to the intensive care unit.
Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor
Pharmacy Times
JUNE 16, 2025
Transportation barriers, as a health-related social need, significantly impact FN rates in chemotherapy patients. Febrile neutropenia (FN) remains a serious and common complication of chemotherapy. A 67% FN rate difference between pegfilgrastim and filgrastim was observed in patients with transportation barriers.
Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy
Pharmacy Times
JUNE 20, 2025
They have a team of highly skilled distribution professionals who can juggle efficacy and safety checks along with compounding as if they were conductors of a world-class symphony. We need people to coordinate and track prior authorizations, write persuasive appeal letters, and keep patients updated.
Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer
Pharmacy Times
JUNE 13, 2025
Vitamin D supplementation increased 25-hydroxyvitamin-D levels significantly, suggesting a potential role in enhancing chemotherapy effectiveness. The study's findings support further research with larger samples to explore vitamin D's impact on chemotherapy and breast cancer remission likelihood.
Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC
Pharmacy Times
JULY 9, 2025
Although improved clinical outcomes with the addition of chemotherapy to ICI have been recorded for some patients, there is ongoing research to understand how prognostic factors (eg, smoking history, tumor histology, performance status) can provide some predictive values for patient response to ICI therapy.
FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults
Pharmacy Times
JUNE 10, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
New Online Competency Modules Standardize CPA Pharmacist Training at Academic Medical Center
Pharmacy Times
JUNE 9, 2025
Related Videos Related Content Advertisement June 9th 2025 Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2. Subscribe Now!
CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies
Pharmacy Times
JUNE 19, 2025
Development Trends: Oncology at the Forefront Gene therapy currently ranks third among therapeutic focus areas, with 2151 compounds in development in 2024 ( Figure ). 2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025. 6 CAR T-cell therapies continue to dominate the genetically modified space.
Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD
Pharmacy Times
JUNE 17, 2025
Conclusions We demonstrated the feasibility of leveraging a complex EHR data source from an integrated health system to study the impact of dose modifications on clinical outcomes for self-administered chemotherapy. Nearly half of the patients with CML on imatinib experienced dosage modifications in this study.
From Med Rec to AI: Pharmacists Expanding Their Role in Oncology Innovation
Pharmacy Times
JULY 23, 2025
So I think the study really showed the benefit of remote clinical monitoring after starting chemotherapy. It frees up appointment slots for patients who need urgent care and helps streamline the process for new patients. Przespolewski : Pharmacists play a large role in managing drug shortages, especially those on the front lines.
Pharmacists at the Frontlines of Innovation in Lung Cancer Care
Pharmacy Times
JUNE 25, 2025
Yes, we currently have antibody-drug conjugates that are conjugated to a cytotoxic chemotherapy. So are there oncogenic proteins that we can actually target that we couldn’t traditionally target with just a small molecule inhibitor? We look at ADCs. Unfortunately, these drugs are quite toxic.
Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer
Pharmacy Times
JUNE 27, 2025
After learning of his diagnosis, our relationship shifted from small talk at school events to detailed discussions in an infusion center setting about chemotherapy, immunotherapy, clinical trials, alternative medicines, and anticipated adverse effects.
Pharmacists Take the Lead on Advanced Therapeutics
Pharmacy Times
JUNE 9, 2025
Related Videos Related Content Advertisement June 9th 2025 Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2. Subscribe Now!
Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC
Pharmacy Times
JUNE 11, 2025
Additionally, patients may have received prior chemotherapy for advanced disease. Additionally, taletrectinib was granted priority review, breakthrough designation, and orphan drug designation for this indication. For both trials, the major efficacy outcomes were confirmed overall response rate (cORR) and duration of response (DOR).
Allopurinol alternatives: What can I take instead of allopurinol?
The Checkup by Singlecare
AUGUST 4, 2025
Probenecid Eliminating urate by increasing urinary excretion of the compound is probenecid’s mechanism of action. This occurs most commonly during chemotherapy. The higher price of Uloric compared to allopurinol’s cost can be another deterrent, but a SingleCare discount card can make the price comparable to allopurinol.
Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia
Pharmacy Times
JUNE 18, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer
Pharmacy Times
JULY 14, 2025
TRE-515 Combined With a Radiopharmaceutical As a precision cancer treatment designed for adults with PSMA-positive mCRPC, lutetium Lu 177 vipivotide tetraxetan is used after individuals have undergone other treatments like androgen receptor pathway inhibition and taxane-based chemotherapy.
Anlotinib Following Benmelstobart Plus Chemotherapy Improves Progression-Free Survival in S-NSCLC
Pharmacy Times
JUNE 25, 2025
Benmelstobart (TQB2450; Chia Tai Tianqing Pharmaceutical Group Co, Ltd) in combination with chemotherapy followed by sequential combination with anlotinib (Catequentinib; Advenchen Laboratories) led to significant improvements in progression-free survival (PFS), with a manageable safety profile. months versus 7.79 months with tislelizumab.
From Trial to Practice in the Evolving Landscape of Hematologic Malignancies
Pharmacy Times
JUNE 18, 2025
Mok : Right now, we have a lot of chemotherapy being used, but there are many more novel treatments being studied, especially in earlier lines of treatment. Bispecifics are moving up in the lymphoma space, and these newer therapies may have some synergistic effects with chemotherapy. REFERENCES 1. Updated August 18, 2021.
Efficacy and Safety in CPX-351 vs 7+3 in Adults Younger Than 60 Years With AML-MRC or t-AML
Pharmacy Times
AUGUST 7, 2025
Methods Patients aged 18 to 59 years with t-AML or AML-MRC treated with CPX-351 or 7+3 as induction chemotherapy between 2015 and 2022 at 3 National Cancer Institute–designated cancer centers were included. Study Design Retrospective, multicenter, observational cohort study. Author Disclosures Brian A.
Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation
Pharmacy Times
JULY 3, 2025
I think it’ll be chemotherapy—maybe their cells being given outpatient—and then, as we hit their hardest time or their highest risk for either febrile neutropenia or mucositis or even some of the toxicities from the chemotherapy, we have them inpatient until we feel comfortable, and then transition it so that it could be all outpatient.
Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer
Pharmacy Times
JUNE 19, 2025
1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patient care, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy. For advanced disease, chemotherapy was the standard.
What You Need to Know as a Breastfeeding Hashi’s Mama
The Thyroid Pharmacist
AUGUST 1, 2025
You can also try using oxytocin nasal spray that you can get prescribed and compounded by your compounding pharmacist, taking Epsom salt baths, or using essential oils like lavender and clary sage. [60] Variations in the rancid-flavor compounds of human breastmilk under general frozen-storage conditions. 2006 Apr;4(4):455-9.
Real-World Data Suggests Cannabis Use is Associated With Major Adverse Cardiovascular Events
Pharmacy Times
JUNE 25, 2025
link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
Study Finds VPS72 Is Overactive in Patients With Hepatocellular Carcinoma
Pharmacy Times
JUNE 6, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Pharmacy Times
JUNE 18, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes
Pharmacy Times
JUNE 17, 2025
Martino, PharmD, BCOP, APh Kaitlyn Wells, PharmD Sam Martinez, PharmD, BCOP, BCPS Craig A. Stevens, PharmD, BCPS June 3rd 2025 S2. Martino, PharmD, BCOP, APh Kaitlyn Wells, PharmD Sam Martinez, PharmD, BCOP, BCPS Craig A. Stevens, PharmD, BCPS June 3rd 2025 S2.
FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer
Pharmacy Times
JUNE 23, 2025
Datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc) received FDA approval for treatment of adults with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) who have received prior EGFR-directed therapy and platinum-based chemotherapy.
ASCO 2025: Evaluating Nivolumab Plus Relatlimab in Resected Stage 3 or 4 Melanoma
Pharmacy Times
JUNE 9, 2025
Related Videos Related Content Advertisement June 9th 2025 Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2. Subscribe Now!
Zai Lab at ASCO 2025: Rafael G. Amado in an Illuminating Dialogue Exchange with PharmaShots
PharmaShots
JULY 23, 2025
ADCs continue to possess the potential to provide a more impactful benefit to patients than chemotherapy alone, with a more limited toxicity profile. All patients in the study had progressed following platinum-based chemotherapy, and 90% of patients had progressed after immune checkpoint inhibitors. and 30% from China. mg/kg, 1.2
Let's personalize your content